Awardee OrganizationCASE WESTERN RESERVE UNIVERSITY
Description
Abstract Text
Project Summary
Aerosol-generating procedures (AGPs) are medical procedures that produce aerosols that can be laden with
pathogens if the patient has a viral infection, such as SARS-CoV-2 or influenza. These aerosols pose a significant
risk to health care workers, as they can linger in the air for extended periods of time and are small enough to
bypass ordinary surgical masks. There is currently no established, unambiguous way to evaluate the risks to
healthcare workers associated with a specific AGP, nor is there a rigorous method by which to assess a proposed
risk-mitigation strategy. To address this gap, a flow visualization technique must be developed that can be applied
in a clinical setting during actual medical procedures and is capable of detecting aerosol-laden flows produced
by AGPs or potential AGPs.
In this R21 proposal, we will adapt background-oriented schlieren (BOS) visualization, a method from fluid
mechanics, into a technique that can be applied to study flows produced by AGPs. The R21 project is high
risk with no published preliminary data, but the PIs have successfully demonstrated visualziation of aerosols
produced by jet ventilation, a specific type of AGP, using BOS in a proof-of-concept experiment. The proposed
work is significant and timely, as assessment of the risk associated with AGPs is extremely important in the
context of the COVID-19 pandemic. We will use the novel BOS technique to assess risks and evaluate mitigation
strategies for three specific AGPs in both ex vivo and in vivo conditions.
Specific Aim 1: Develop a human-scale BOS system and establish a procedure for evaluating the risk
of AGPs in a clinical setting.
Specific Aim 2: Quantify the risk of aerosol exposure under different simulated and in-vivo conditions,
and identify strategies to mitigate the risks.
The significance and impact of the proposed research will be in developing a tool for unambiguously evaluat-
ing the risks associated with AGPs in realistic clinical settings, and urgently-needed risk assessments for three
specific AGPs and experimentally verified risk mitigation strategies for each.
Public Health Relevance Statement
Project Narrative
Aerosol-generating procedures are medical procedures that can potentially produce pathogen-laden aerosols that
pose a risk to healthcare providers. This has become a significant issue as a result of the COVID-19 pandemic,
but it is crucial that the risks associated with specific procedures can be evaluated in a rigorous way not just for
the current pandemic but for any future disease outbreaks as well. New tools are needed to assess these risks
and develop mitigation strategies, and the primary focus of this exploratory project is to develop such a tool and
use it to evaluate risk for several key procedures.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
077758407
UEI
HJMKEF7EJW69
Project Start Date
01-January-2022
Project End Date
30-November-2025
Budget Start Date
01-December-2023
Budget End Date
30-November-2025
Project Funding Information for 2024
Total Funding
$188,918
Direct Costs
$125,000
Indirect Costs
$63,918
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$188,918
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21EB032644-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21EB032644-03
Patents
No Patents information available for 5R21EB032644-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21EB032644-03
Clinical Studies
No Clinical Studies information available for 5R21EB032644-03
News and More
Related News Releases
No news release information available for 5R21EB032644-03
History
No Historical information available for 5R21EB032644-03
Similar Projects
No Similar Projects information available for 5R21EB032644-03